Microsatellite instability and Epstein-Barr virus infection in gastric remnant cancers

被引:37
作者
Chang, MS
Lee, JH
Kim, JP
Kim, HS
Lee, HS
Kim, CW
Kim, YI
Kim, WH
机构
[1] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 110799, South Korea
关键词
Epstein-Barr virus; gastric remnant cancer; microsatellite instability; neoplasm; stomach;
D O I
10.1046/j.1440-1827.2000.01072.x
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Clinicopathological analysis, microsatellite analysis, detection of Epstein-Barr virus (EBV), and immunohistochemistry on p53 protein were performed in 26 cases of gastric remnant cancer (GRC). They were divided into two groups; Group A (n = 14) who had undergone a primary gastrectomy for benign gastric disease, and Group B (n = 12) who had undergone the same operation for gastric cancer. EBV infection was present in 29% of Group A, 8% of Group B and 6% of the conventional gastric carcinoma (CGC) (Group A vs CGC, P = 0.01). Microsatellite instability (MSI) was found in 7% of Group A, 25% of Group B, and 9% of the CGC (Group B vs CGC; P = 0.08). p53 Overexpression was observed in 46% of the GRC and 33% of the CGC. p53 Overexpression was observed in 90% of the intestinal type of GRC, but in only 20% of the diffuse type of GRC (P = 0.002). The cancer stage was a significant factor in the univariate analysis of survival (P = 0.04). In conclusion, GRC is different from CGC in terms of MSI or EBV association. The pathogenetic differences between the two groups require further investigation. EBV infection may have been involved in the carcinogenesis of Group A. MSI may be an important factor in the carcinogenesis of metachronous multiple gastric cancer (Group B).
引用
收藏
页码:486 / 492
页数:7
相关论文
共 35 条
  • [1] American Joint Committee on Cancer, 1997, STOMACH CANC, P71
  • [2] CHONG JM, 1994, CANCER RES, V54, P4595
  • [3] Origin of microsatellite instability in gastric cancer
    Halling, KC
    Harper, J
    Moskaluk, CA
    Thibodeau, SN
    Petroni, GR
    Yustein, AS
    Tosi, P
    Minacci, C
    Roviello, F
    Piva, P
    Hamilton, SR
    Jackson, CE
    Powell, SM
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (01) : 205 - 211
  • [4] HAN HJ, 1993, CANCER RES, V53, P5087
  • [5] Herrera-Goepfert R, 1999, MODERN PATHOL, V12, P873
  • [6] P53 MUTATIONS IN HUMAN CANCERS
    HOLLSTEIN, M
    SIDRANSKY, D
    VOGELSTEIN, B
    HARRIS, CC
    [J]. SCIENCE, 1991, 253 (5015) : 49 - 53
  • [7] Iacopetta BJ, 1999, J PATHOL, V187, P428, DOI 10.1002/(SICI)1096-9896(199903)187:4<428::AID-PATH264>3.0.CO
  • [8] 2-A
  • [9] GASTRIC-CARCINOMA - MONOCLONAL EPITHELIAL MALIGNANT-CELLS EXPRESSING EPSTEIN-BARR-VIRUS LATENT INFECTION PROTEIN
    IMAI, S
    KOIZUMI, S
    SUGIURA, M
    TOKUNAGA, M
    UEMURA, Y
    YAMAMOTO, N
    TANAKA, S
    SATO, E
    OSATO, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 9131 - 9135
  • [10] Kaminishi M, 1996, CANCER, V77, P1646, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1646::AID-CNCR10>3.0.CO